CHEK2 and chronic myelogenous leukemia, BCR-ABL1 positive: These data are consistent with recently published evidence for ongoing DNA damage and DDR detected by activated ATM, Chk2, and γH2AX accumulation in PB-MNCs of de novo untreated CP-CML patients [39].